We are live on ! Find out more
IDXX icon

Idexx Laboratories

613 hedge funds and large institutions have $11.9B invested in Idexx Laboratories in 2017 Q4 according to their latest regulatory filings, with 79 funds opening new positions, 162 increasing their positions, 265 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

119% more first-time investments, than exits

New positions opened: 79 | Existing positions closed: 36

7% more funds holding

Funds holding: 573613 (+40)

0% more funds holding in top 10

Funds holding in top 10: 1515 (0)

7% less capital invested

Capital invested by funds: $12.8B → $11.9B (-$902M)

16.3% less ownership

Funds ownership: 103.58%87.28% (-16%)

39% less repeat investments, than reductions

Existing positions increased: 162 | Existing positions reduced: 265

49% less call options, than puts

Call options by funds: $16.5M | Put options by funds: $32.3M

Holders
613
Holders Change
+40
Holders Change %
+6.98%
% of All Funds
13.9%
Holding in Top 10
15
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.34%
New
79
Increased
162
Reduced
265
Closed
36
Calls
$16.5M
Puts
$32.3M
Net Calls
-$15.8M
Net Calls Change
-$13.3M
Name Holding Trade Value Shares
Change
Change in
Stake
CRC
176
Curi RMB Capital
Illinois
$4.32M +$95.2K +605 +2%
MIM
177
MetLife Investment Management
New Jersey
$4.22M +$4.25M +26,986 New
Envestnet Asset Management
178
Envestnet Asset Management
Illinois
$4.19M +$234K +1,487 +6%
MCM
179
Matarin Capital Management
New York
$4.1M +$2.05K +13 +0%
FAF
180
Fjarde Ap-fonden
Sweden
$4.07M +$710K +4,509 +21%
CWM
181
CIBC World Markets
New York
$4.07M +$955K +6,065 +30%
AP
182
AHL Partners
United Kingdom
$4.01M -$910K -5,782 -18%
SOMRS
183
State of Michigan Retirement System
Michigan
$4M -$142K -900 -3%
RJA
184
Raymond James & Associates
Florida
$4M -$2.36M -15,014 -37%
SSA
185
Schonfeld Strategic Advisors
New York
$3.92M -$1.69M -10,721 -30%
JG
186
Jefferies Group
New York
$3.78M +$1.02M +6,473 +37%
AAMU
187
Amundi Asset Management US
Massachusetts
$3.75M +$3.77M +23,972 New
TPSF
188
Texas Permanent School Fund
Texas
$3.72M -$59.2K -376 -2%
BCM
189
Brasada Capital Management
Texas
$3.7M +$3.72M +23,660 New
FT
190
Fiduciary Trust
Massachusetts
$3.69M -$499K -3,169 -12%
HPC
191
HM Payson & Co
Maine
$3.69M +$246K +1,563 +7%
NA
192
Navellier & Associates
Nevada
$3.65M -$6.01M -38,206 -62%
Calamos Advisors
193
Calamos Advisors
Illinois
$3.61M -$85.2K -541 -2%
UCFA
194
United Capital Financial Advisors
Texas
$3.49M +$1.64M +10,399 +90%
BFO
195
Boston Family Office
Massachusetts
$3.44M +$156K +993 +5%
Zurich Cantonal Bank
196
Zurich Cantonal Bank
Switzerland
$3.42M +$281K +1,787 +9%
DnB Asset Management
197
DnB Asset Management
Norway
$3.42M +$551K +3,500 +19%
TI
198
Trexquant Investment
Connecticut
$3.32M +$3.34M +21,222 New
Bank of Nova Scotia
199
Bank of Nova Scotia
Ontario, Canada
$3.26M -$2.49M -15,838 -43%
IG
200
ING Group
Netherlands
$3.26M +$2.81M +17,840 +599%

IDXX Hedge Fund Activity: Q4 2017 in Review

613 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Idexx Laboratories (IDXX) for Q4 2017, worth a combined $11.9B — down 7.1% from $12.8B a quarter earlier.

Buyers outnumbered sellers: 79 funds opened new IDXX positions and 36 closed out — a net gain of 43 holders — while 162 added to existing stakes and 265 trimmed.

The largest buyer was William Blair Investment Management, adding an estimated $78.8M. The largest seller was Fundsmith LLP, cutting an estimated $2.22B.

  • 613 institutional investors held Idexx Laboratories (IDXX) as of Q4 2017, up from 573 in Q3 2017.
  • Funds reported $11.9B of Idexx Laboratories stock for Q4 2017, down 7.1% quarter-over-quarter.
  • 79 funds opened new Idexx Laboratories positions in Q4 2017 and 36 closed out, a net change of +43 holders.
  • The largest Idexx Laboratories buyer in Q4 2017 was William Blair Investment Management, an estimated $78.8M added.
  • The largest Idexx Laboratories seller in Q4 2017 was Fundsmith LLP, an estimated $2.22B sold.

Based on aggregated 13F filings for Q4 2017.